Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: A french multicenter study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 33, Issue 2, 2001, Pages 122-126

  Viola, Sheila ^a   Benlian, Pascale ^b   Morali, Alain ^c   Dobbelaere, Dries ^c   Lacaille, Florence ^c   Rieu, Daniel ^c   Ginies, Jean Louis ^c   Maurage, Chantal ^c   Meyer, Martine ^c   Lachaux, Alain ^c   Larchet, Michel ^c   Lenearts, Catherine ^c   Goulet, Olivier ^c   Sarles, Jacques ^c   Mouterde, Olivier ^c   Girardet, Jean Philippe ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c French Speaking Group for Pediatric Hepatogastroenterolgy and Nutrition   (France)

Author keywords

Apolipoprotein B; Familial combined hyperlipidemia; Familial defective apo B 100; Hypercholesterolemia; Polygenic hypercholesterolemia

Indexed keywords

APOLIPOPROTEIN B; ARGININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPERLIPIDEMIA; INFANT; MALE; MASS SCREENING; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING;

ADOLESCENT; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; FEMALE; FRANCE; GENE FREQUENCY; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; MALE; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION MAPPING; RISK FACTORS;

EID: 17944378174     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200108000-00005     Document Type: Article

References (38)

1. Serum cholesterol, blood pressure and mortality: Implication from a cohort of 361662 men
2. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
3. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (ages ≤50 years) and women (≤60 years) with coronary artery disease
4. Familial hypercholesterolemia
5. A worldwide web site for LDLR gene mutations in FH: Sequence-based, tabular, and direct submission data handling
6. Mortality in treated heterozygous familial hypercholesterolemia: Implications for clinical management
7. In vivo evidence for reduced binding of low-density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia
8. Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia
9. Familial defective apolipoprotein B-100: A single mutation that causes hypercholesterolemia and premature coronary artery disease
10. Familial defective apolipoprotein B-100: A review, including some comparisons with familial hypercholesterolemia
11. Apolipoprotéine B, un locus pour deux maladies
12. Familial defective apolipoprotein B-100
13. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia
14. Familial defective apolipoprotein B100. Clinical characteristics in 54 cases
15. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low-density lipoprotein receptor function
16. Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries
17. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia
18. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B100 and familial hypercholesterolemia
19. High prevalence of familial defective apolipoprotein B-100 in Switzerland
20. Identification of the apo B-3500 mutation in the Norwegian population
21. Familial defective apolipoprotein B100: A study of patients from lipid clinics in Scotland and Wales
22. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease
23. Familial defective apolipoprotein B-100 and myocardial infarction: The ECTIM study
24. Familial ligand-defective apolipoprotein B-100: Simultaneous detection of the Arg3500Gln and Arg3531Cys mutations in a French population
25. Incidence of the apolipoprotein B-3500 mutation in Denmark
26. Valeurs de référence du cholestérol et des triacylglycérols plasmatiques et lipoprotéiniques chez des enfants sains
27. Valeurs usuelles observées en fonction de l'age et du sexe chez des personnes ayant bénéficié d'un examen de santé
28. Body mass index variation: Centiles from birth to 87 years
29. Clinical implications of familial hypercholesterolemia in childhood
30. Detection of the apo B-3500 mutation (glutamine for arginine) by gene amplification and cleavage by Msp1
31. Rapid testing for three mutations causing familial defective apolipoprotein B 100 in 562 patients with familial hypercholesterolemia
32. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary heart disease, and receptor binding of low-density lipoproteins
33. Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: Identification of a unique haplotype of the apolipoprotein B-100 allele
34. Mutations in the apolipoprotein (apo) B-100 receptor-binding region: Detection of apo B-100 (Arg3500Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405Gln) diminishes receptor-mediated uptake of LDL
35. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds
36. Rare and common mutations in hyperlipidemia and atherosclerosis
37. Committee report: Childhood diet prevention of coronary heart disease
38. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia